Evista 60 mg

Evista 60 mg tablets contain raloxifene hydrochloride, a selective estrogen receptor modulator (SERM) used for osteoporosis prevention and treatment. This medication is designed to help maintain bone density and reduce fracture risk in postmenopausal women.

Evista 60 mg tablets are primarily used to prevent and treat osteoporosis in postmenopausal women. Raloxifene works by mimicking estrogen's effects on bone, helping to maintain bone density and reduce the risk of fractures. It is also used to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis or at high risk for the disease. What is Evista used for? Evista is used for managing bone health and reducing certain cancer risks in postmenopausal women.

Common effects of Evista 60 mg tablets may include hot flashes, leg cramps, and fluid retention. Some users might experience swelling in the hands or feet. These effects vary among individuals and are not experienced by everyone. It's important to discuss any persistent or severe effects with a healthcare provider.

Evista 60 mg tablets should be handled with care, especially for those with a history of blood clots or liver disease. It is essential to follow the prescribed dosage and administration guidelines. Regular monitoring may be required to assess the medication's effects on bone density and overall health.

Evista 60 mg tablets may interact with certain medications, including cholesterol-lowering drugs and some antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect how Evista works in the body.